Topic hub

  • Weight management
  • Pharmacy

UK and Republic of Ireland obesity and weight management market

6,387 of 6,675 UK locations record weight management programmes, the clearest headline finding in this cohort. Medicated weight management appears at 6,229 locations, while the Republic of Ireland records 209 weight management locations. Across both markets, the classification covers seven categories spanning programmes, medication, genetic and biomarker-based treatments, bariatric surgery and gastric balloons.

About this market

The Association for the Study of Obesity is the UK organisation dedicated to obesity research, education, prevention and treatment. The Health Service Executive sets out obesity care and weight management routes in the Republic of Ireland. Both reflect a field that spans structured programmes, clinical assessment, medication and specialist intervention.

Rare.Monitor groups locations by the treatments recorded at each address. One location can carry several categories, so the category figures overlap rather than adding up to the market total. This page holds the current figures and every Rare. analysis of the obesity and weight management segment.

Programmes and medication reach more than nine in ten UK locations

6,387 of the 6,675 UK locations record weight management programmes, a 95.7% share of the UK cohort. Medicated weight management appears at 6,229 of the same 6,675 locations, or 93.3%. Those two broad categories define the recorded market far more than any individual procedure.

Genetic and biomarker-based treatments appear at 2,516 of the 6,675 UK locations, or 37.7%. The four surgical and device categories each account for less than 12.0% of the same UK cohort. Adjustable gastric banding appears at 782 of 6,675 locations, or 11.7%. Gastric bypass surgery appears at 728 of 6,675, or 10.9%. Sleeve gastrectomy appears at 629 of 6,675, or 9.4%, while gastric balloons appear at 260 of 6,675, or 3.9%.

In the UK cohort, the 6,387 programme locations and 6,229 medicated weight management locations can include the same addresses. A location recording a programme can also record medication, biomarker-based treatment or surgery. The figures describe which services are present at an address. They do not describe treatment volumes or patient numbers.

Scotland has the highest UK share, while the South East has the highest volume

761 of Scotland's 18,661 tracked locations record weight management, the highest regional share at 4.1%. The South East records the largest volume, with 964 of the 6,674 UK weight management locations in the regional cut, but 964 of its 35,748 tracked locations represent a 2.7% regional share.

The West Midlands follows Scotland by share, with 619 of 19,326 tracked locations, or 3.2%. The North West records 755 of 24,292 tracked locations, or 3.1%, while London records 709 of 22,947, also 3.1%. The South East leads the regional cut with 964 weight management locations, while Scotland leads on share at 4.1% of its tracked estate.

Northern Ireland records 130 of its 6,852 tracked locations in the category, a 1.9% share. The East of England records 564 of 24,310, or 2.3%. These figures show the composition of Rare.Monitor's tracked estate. They do not measure local demand, access to treatment or quality of care.

What the data is used for

6,675 UK locations can be filtered by treatment category and region to show where programmes, medication and specialist procedures are recorded. The same location-level view shows where a service is present, where it is absent from the tracked estate and how the mix changes from one UK region to another.

Co-tagging also connects this market to adjacent segments. Musculoskeletal provision appears at 4,127 of the 6,675 UK weight management locations, or 61.8%. Medical aesthetics appears at 1,649 of 6,675, or 24.7%. Dermatology appears at 918 of 6,675, or 13.8%. These are shared location tags, not evidence of shared ownership, patients or a commercial relationship.

Rare.Monitor

Access the full UK weight management dataset

See the underlying locations, ownership links and brand detections in Rare.Monitor.

Book a Demo

FAQ

Frequently asked questions

Questions answered from Rare.Monitor data, figures read 20 August 2026.

  • How many UK locations offer weight management treatment?
    Rare.Monitor records weight management provision at 5,641 approved UK locations. That figure counts all three kinds of provision in the classification: prescribed weight-loss medicines, bariatric surgery, and behavioural programmes. The tag is detected from what each location publishes about its own treatments, so the count records provision rather than measuring the whole market. Source: Rare.Monitor, figures read 20 August 2026.
  • What counts as weight management provision in Rare.Monitor data?
    Weight management in Rare.Monitor covers three kinds of provision recorded from a location's own published text: medicated weight management, where a prescribed weight-loss medicine is named; bariatric surgery, including gastric bypass, sleeve gastrectomy and gastric balloons; and behavioural weight management programmes. This hub's figure counts all three. Source: Rare.Monitor.
  • How is UK weight management provision structured by ownership?
    Rare.Monitor links the 5,641 approved UK locations recording weight management provision to 680 distinct owner records. Rare.Monitor counts distinct owner records rather than how many locations each owner holds, so these figures do not show how concentrated ownership is or how many providers operate from a single site. Locations approved most recently have not yet been matched to an owner record, so 680 counts the owners matched so far rather than every owner behind these locations. Source: Rare.Monitor, figures read 20 August 2026.
  • What does Rare.Monitor track in the obesity treatment segment?
    Rare.Monitor tracks treatment classifications, brand mentions and ownership links across more than 230,000 reportable locations in the United Kingdom and Republic of Ireland (ROI). For obesity treatment that covers which weight-loss treatments each UK location publishes, which medicine brands it names, and which organisation owns it. Records are built from what each location publishes, so figures are restated on each new market read. Source: Rare.Monitor, platform figures read 4 August 2026.
  • When were the weight management locations on this page approved into the dataset?
    The 5,641 UK weight management locations on this page were approved into the Rare.Monitor dataset between February and August 2026. Approval is the point at which a location's record passes review and enters the reportable set. Classification passes then run in a rolling nine to ten week window, so a location's treatment detail can be refreshed after its approval date. Source: Rare.Monitor, figures read 20 August 2026.

Methodology: Rare.Monitor figures were read from the frozen evidence pack at 15:22:04 UTC on 28 August 2026. Counts cover approved, named locations with a postcode, country and eligible data source, classified under weight management. The UK regional cut was read 36 seconds later and contains 6,674 locations, one fewer than the frozen UK headline count of 6,675 locations. The Republic of Ireland is reported as a count only because 191 of its 209 locations, or 91.4%, come from one source and zero of its 209 locations match an owner record. Category and co-tag figures overlap because one location can carry more than one tag.